Equities

Apyx Medical Corp

Apyx Medical Corp

Actions
  • Price (USD)1.52
  • Today's Change-0.14 / -8.43%
  • Shares traded261.33k
  • 1 Year change-56.32%
  • Beta1.2451
Data delayed at least 15 minutes, as of May 10 2024 20:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Apyx Medical Corporation is an advanced energy technology company. The Company's segments include Advanced Energy and OEM. The Advanced Energy segment's product portfolio consists of its Helium Plasma Technology that is marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. It is focused on the cosmetic surgery market where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians an ability to provide controlled heat to the tissue to achieve their desired results. Its product lines consist of a multifunction generator, a handpiece and a supply of helium gas. The OEM segment leverages its expertise in the design, development and manufacturing of electrosurgical equipment and medical devices by producing generators, medical devices and related accessories for medical device manufacturers through original equipment manufacturing agreements, as well as start-up companies with the need for its energy-based designs.

  • Revenue in USD (TTM)50.45m
  • Net income in USD-22.81m
  • Incorporated1982
  • Employees252.00
  • Location
    Apyx Medical Corp5115 Ulmerton RdCLEARWATER 33760-4004United StatesUSA
  • Phone+1 (727) 384-2323
  • Fax+1 (631) 421-5821
  • Websitehttps://apyxmedical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
DarioHealth Corp20.35m-63.51m49.25m276.00--0.7763--2.42-2.24-2.240.71742.140.18882.214.2573,739.13-55.13-73.26-64.69-87.5929.4029.54-292.00-293.543.38--0.3293---26.4122.450.5091--52.42--
InspireMD Inc6.21m-19.92m51.72m65.00--1.22--8.33-1.08-1.080.25651.810.17172.364.3795,461.54-55.10-60.59-65.08-72.9729.1220.46-320.97-334.786.99--0.00--20.0011.50-7.71--41.57--
Milestone Scientific Inc9.83m-6.93m52.01m17.00--6.43--5.29-0.0949-0.09490.13460.10560.78390.851419.53578,085.30-55.68-55.48-73.81-74.7269.1363.97-71.04-88.942.21--0.0013--11.600.423320.41---7.99--
Heartbeam Inc0.00-14.64m52.92m15.00--3.32-----0.9404-0.94040.000.60530.00----0.00-138.30---159.89--------------0.00-------12.94------
Icecure Medical Ltd3.23m-14.65m53.50m71.00--4.40--16.57-0.3211-0.32110.07080.2660.13860.751835.6845,478.88-62.89-54.89-76.33-68.6640.2649.87-453.76-313.193.08--0.00--4.6723.5013.70--48.10--
Beyond Air Inc689.00k-66.70m54.62m98.00--2.03--79.27-2.13-2.130.02190.58670.0111.441.247,030.61-112.64-70.88-148.49-88.69-115.24---10,288.68-1,530.313.26--0.382-------29.27------
Autonomix Medical Inc0.00-10.68m57.13m3.00---------0.5055-0.50550.00-0.2649------0.00----------------------------84.50------
Hyperfine Inc11.03m-44.24m57.40m131.00--0.679--5.20-0.6205-0.62050.15471.170.09671.124.1784,213.74-38.76---42.00--43.12---401.00--9.39--0.00--61.90--39.54------
Apyx Medical Corp50.45m-22.81m57.51m252.00--2.84--1.14-0.6596-0.65961.460.58460.79141.774.49200,202.40-35.94-25.24-46.73-29.9763.7066.11-45.41-46.004.94-9.210.6207--17.6125.8219.28--7.99--
Medinotec Inc3.05m-566.90k58.67m29.00--28.27--19.24-0.0483-0.04830.25980.17690.67122.0616.96105,130.70-12.48---13.23--53.56---18.59--8.571.440.4323---3.91---184.47------
Alpha Pro Tech, Ltd.60.92m4.21m61.13m124.0014.540.964911.901.000.35960.35965.225.420.89081.688.21491,250.006.1615.216.3316.0638.1940.236.9212.9315.31--0.000.00-1.215.6027.642.935.50--
Sensus Healthcare Inc24.41m485.00k62.46m35.00130.701.2882.182.560.02920.02921.502.980.4421.131.75697,314.300.878310.290.984412.1457.6162.851.9915.298.23--0.00---45.20-1.58-98.00---23.16--
IR-MED Inc0.00-4.91m62.94m6.00--172.43-----0.0714-0.07140.000.00520.00----0.00-228.70---310.89--------------0.3061-------3.70------
Pro-Dex Inc48.24m5.00m63.08m146.0013.272.0610.441.311.391.3913.448.980.97462.303.68330,438.3010.1115.4312.9418.8728.2533.1510.3714.922.16--0.27530.009.6215.4654.7232.380.8422--
Vivos Inc19.50k-2.89m63.15m10.00--46.35--3,238.42-0.0079-0.00790.000050.00350.0116--2.17---172.67-202.25-191.32-552.77-30.9710.79-14,844.92-11,969.07----0.00---46.58---17.19------
Envoy Medical Inc316.00k-29.91m65.66m34.00------207.78-2.60-2.600.0207-0.0899------9,294.12---------149.68---9,464.56--0.8169-266.25----33.33---87.83------
Data as of May 10 2024. Currency figures normalised to Apyx Medical Corp's reporting currency: US Dollar USD

Institutional shareholders

33.16%Per cent of shares held by top holders
HolderShares% Held
Archon Capital Management LLCas of 31 Dec 20233.45m9.96%
Royce & Associates LPas of 31 Dec 20232.16m6.23%
The Vanguard Group, Inc.as of 31 Dec 20231.47m4.24%
RTW Investments LPas of 31 Dec 20231.03m2.96%
Taylor Frigon Capital Management LLCas of 31 Mar 2024637.71k1.84%
Silverberg Bernstein Capital Management LLCas of 31 Mar 2024621.39k1.79%
Horizon Kinetics Asset Management LLCas of 31 Dec 2023615.00k1.78%
Worth Venture Partners LLCas of 31 Dec 2023518.20k1.50%
Commonwealth Equity Services LLCas of 31 Mar 2024497.08k1.44%
BlackRock Fund Advisorsas of 31 Dec 2023492.34k1.42%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.